Supplementary Figure 1 from VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC

Authors :: Robert M. Hershberg
Mary L. Disis
James Jeffry Howbert
Katherine E. Henderson
Vernon C. Maino
Maria Suni
Margaret Inokuma
Smita Ghanekar
Yi Yang
Maura-Ann H. Matthews
Gregory N. Dietsch
Hailing Lu
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 105K

Full Text Access

Tools